Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stuart A. Arbuckle currently holds 3,279 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart A. Arbuckle has been a net seller of VRTX stock. They have purchased $0 and sold $139.9M worth of shares.
Stuart A. Arbuckle's most recent insider trade was on Jan 5, 2026, when they sold 3,279 shares at $0.00 per share.
Stuart A. Arbuckle serves as Executive at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have executed 408 insider transactions totaling $139.9M over their tenure at the company.
Stuart A. Arbuckle holds the position of Executive at VERTEX PHARMACEUTICALS INC / MA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Stuart A. Arbuckle has shown a selling trading pattern, with $0 in total purchases and $139.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stuart A. Arbuckle was on Jul 1, 2025, when they sold $16.8M worth of VRTX shares. This transaction involved 37,243 shares at $450.23 per share.
Stuart A. Arbuckle currently owns 3,279 shares of VERTEX PHARMACEUTICALS INC / MA (VRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stuart A. Arbuckle's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stuart A. Arbuckle has 408 Form 4 filings on record as an insider at VERTEX PHARMACEUTICALS INC / MA.
Set alerts for Stuart A. Arbuckle and 40,000+ other insiders.